A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry

Bárbara Angulo(Hospital Universitario HM Sanchinarro), Fernando López‐Ríos(Hospital Universitario 12 De Octubre)

PLoS ONE

August 27, 2012

10.1371/journal.pone.0043842

Cited by 107

Related Papers

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

|Clinical & Translational Oncology|2019|104

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

|Journal of Thoracic Oncology|2019|71

Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing

|Cancers|2021|34